Humana elects Robert S. Field to board, effective after 2026 annual meeting

HUMANA INC

Board expanded from 10 to 11 directors; Field elected effective April 16, 2026.
Field is Principal & Managing Member of ηMed Capital Management, a healthcare-services investment firm.
Board determined Field qualifies as independent under NYSE standards; no committee assignments yet.
Field will receive restricted stock units under Humana's director compensation program.
Field previously served at Luxor Capital and McKinsey; brings investor and legal expertise.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.